[stm_post_info]
A landmark cancer drug approved last year seemed to herald a long-anticipated change in the treatment of some tumours: with medicines selected on the basis of molecular markers, rather than the tissue in which the cancer first took root.
Noticia completa
[vc_widget_sidebar sidebar_id=»default»]